Foundation Medicine's chief executive Michael Pellini gave a nod to the deal with Google during a corporate earnings call on Wednesday, according to a person who listened in. Pellini said Google employees were made aware of this new benefit last week.
Google declined to comment.
Foundation Medicine helps steer oncologists to a drug treatment based on the patient's genetic profile. Its two commercially available tests range from $5,800 to $7,200.
Google will start covering these tests in January, 2015.
This move from Google follows an announcement from Silicon Valley tech companies Apple and Facebook that they would begin covering the cost of egg freezing for female employees.
In Silicon Valley, where software developers are in short supply, companies are competing to offer new health benefits as a key means to recruit and retain talent.
Google's investment arm Google Ventures has previously invested in Foundation Medicine. Google Ventures' partner Krishna Yeshwant sits on Foundation Medicine's board.
© Thomson Reuters 2014
Catch the latest from the Consumer Electronics Show on Gadgets 360, at our CES 2026 hub.
NOAA Issues G2 Solar Storm Watch; May Spark Auroras but Threaten Satellite Signals
Freedom at Midnight Season 2 Streams on Sony LIV From January 9: What to Know About Nikkhil Advani’s Historical Drama
Researchers Develop Neuromorphic ‘E-Skin’ to Give Humanoid Robots Pain Reflexes
Naanu Matthu Gunda 2 Now Streaming on ZEE5: Where to Watch Rakesh Adiga’s Emotional Kannada Drama Online?